IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ZION
Zions Bancorporation, National Association
ZION's fundamentals are strong: its operating margin rose 8 points to 41% and revenue grew 13%. At 8.1x earnings, it's trading below its usual 9.8x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ZION Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ZION's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ZION.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ZION PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $66.14 | +0.3% |
| Current | 8.1x | $65.95 | — |
| Forward | 9.7x | $65.95 | — |
| Fair | 9.8x | $79.72 | +21% |
| Expensive | 12x | $98.31 | +49% |
Historical ranges are pointers, not guarantees.
ZION's PE is in its cheap range at 8.1x. On analysts' estimates for next year's earnings, today's price would be 9.7x, in its fair range.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ZION Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
ZION has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ZION Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.81 | -16% |
| Q3 2026 | $8.15 | +46% |
| Q2 2026 | $7.85 | +44% |
| Q1 2026 | $6.43 | +26% |
| Q4 2025 | $6.00 | +21% |
| Q3 2025 | $5.58 | +27% |
| Q2 2025 | $5.47 | +32% |
| Q1 2025 | $5.12 | +29% |
| Q4 2024 | $4.95 | +14% |
ZION has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ZION Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $881M | +2.3% |
| Q2 2026 | $1.1B | +36% |
| Q1 2026 | $849M | +6.8% |
| Q4 2025 | $891M | +8.7% |
| Q3 2025 | $861M | +8.7% |
| Q2 2025 | $838M | +7.9% |
| Q1 2025 | $795M | +7.1% |
| Q4 2024 | $820M | +12% |
ZION's revenue has grown year over year for nine quarters in a row: $881M last quarter, up 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | +5 points |
| Q2 2026 | 51% | +14 points |
| Q1 2026 | 35% | +4.6 points |
| Q4 2025 | 38% | +5.1 points |
| Q3 2025 | 33% | -1.9 points |
| Q2 2025 | 37% | +3.5 points |
| Q1 2025 | 30% | +2.7 points |
| Q4 2024 | 33% | +12 points |
ZION has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ZION Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $860M | +108% |
| Q2 2026 | $389M | +$482M |
| Q1 2026 | $398M | +162% |
| Q4 2025 | $480M | -1.8% |
| Q3 2025 | $413M | +326% |
| Q2 2025 | -$93M | -140% |
| Q1 2025 | $152M | -34% |
| Q4 2024 | $489M | +$763M |
ZION has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ZION Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.1M shares |
| 1 year | -1.4% | -2M shares |
| 3 years | -1.7% | -2.6M shares |
| 5 years | -9.6% | -15.4M shares |
| Available history | -22% | -41.4M shares |
ZION has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $75M |
| Q2 2026 | $75M |
| Q1 2026 | $77M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $41M |
| Q4 2024 | $1M |
ZION spent $227M buying back its own shares over the past year, about five times what it spent the year before.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ZION Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.0x | Healthy |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 1.0x | Very low |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 3.6x | Elevated |
ZION's net debt is about a year of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like ZION.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ZION Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.8 | Neutral |
| Stochastic | 38.7 | Neutral |
ZION's weekly RSI is 52 (neutral) and its Stochastic is 39 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ZION PE vs Financial Services Sector
| Metric | ZION | Sector median | Relative |
|---|---|---|---|
| PE | 8.1x | 13x | 38% below |
| PE % | 16 | 63 | 47 pts below |
ZION is trading at 8.1x earnings, a 38% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ZION Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $64.4 | 2.4% above |
| 20 week MA | $67.4 | 2.2% below |
| 50 week MA | $63.3 | 4.2% above |
| 100 week MA | $57.8 | 14% above |
| 200 week MA | $49.4 | 34% above |
ZION has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
ZION Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.5 | $43.3 | -16% |
| 2021 | $43.3 | $62.4 | +44% |
| 2022 | $62.4 | $48.5 | -22% |
| 2023 | $48.5 | $43.9 | -9.5% |
| 2024 | $43.9 | $54.7 | +25% |
| 2025 | $54.7 | $59.5 | +8.8% |
| 2026 YTD | $59.5 | $66.0 | +11% |
ZION has the edge over IREN on returns for 2026, with the stronger performance.